期刊文献+

慢性荨麻疹患者幽门螺杆菌检测的意义 被引量:14

Significance of HP detection in patients of chronic urticaria
在线阅读 下载PDF
导出
摘要 目的:研究慢性荨麻疹与幽门螺杆菌(Helicobacter pylori,HP)感染的相关性,探讨HP检测在慢性荨麻疹患者诊疗中的意义。方法:选取2014年4月至2015年7月门诊治疗的慢性荨麻疹患者420例,并随机选取同期体检中心健康体检者450例为健康对照组,采用胶体金法检测患者及健康体检者血清HP尿素酶抗体,分析慢性荨麻疹组和健康对照组两组HP的阳性情况;同时将162例慢性荨麻疹HP阳性患者分为实验组88例和对照组74例,对照组患者应用常规荨麻疹治疗,实验组患者在对照组治疗基础上增加抗HP三联疗法,分析HP检测阳性的慢性荨麻疹患者采用不同治疗方法的临床疗效。结果:慢性荨麻疹组HP阳性率为38.6%,健康对照组HP阳性率为14.4%,差异有统计学意义(P<0.05);HP检测阳性患者实验组临床疗效有效率显著高于对照组的有效率,差异有统计学意义(P<0.05)。结论:慢性荨麻疹与HP感染之间存在密切的相关性,HP检测对慢性荨麻疹患者的诊疗具有重要的临床意义。 Objective: To study the correlation between chronic urticaria and Helicobacter pylori infection,and to explore the significance of HP detection in the diagnosis and treatment of chronic urticaria. Methods: Totally 420 cases of chronic urticaria,who were treated in outpatient department from April 2014 to July 2015,and 450 cases of healthy physical people were selected randomly as healthy control group in the same period,then the serum HP unease antibody was detected by colloidal gold method,the positive rate of two groups patients with HP was analysed. Meanwhile 162 chronic urticaria patients with positive HP were divided into experimental group with 88 cases and control group with 74 cases. The patients in the control group were treated with conventional treatment,while the experimental group were treated with triple therapy based on the treatment of control group,and the clinical efficacy of different therapeutic methods was analysed in the chronic urticaria patients with positive HP. Results: The positive rate of HP in chronic urticaria group was 38. 6%,and the positive rate of HP in healthy control group was 14. 4%,the difference was statistically significant( P〈0. 05). The effective rate of clinical efficacy in the experimental group was significantly higher than the control group( P〈0. 05). Conclusion: There is close correlation between chronic urticaria and HP infection,HP detection has important clinical significance for the diagnosis and treatment of chronic urticaria.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2016年第7期1050-1052,共3页 Chinese Journal of Immunology
关键词 慢性荨麻疹 幽门螺杆菌 胶体金法 Chronic urticaria Helicobacter pylori Colloidal gold method
作者简介 作者简介:王春苗(1986年-),女,硕士,技师,主要从事检验与免疫方面的研究,E-mail:ehunmia0306@163.com。 通讯作者及指导教师:周茂华(1970年-),女,博士,主任技师,主要从事临床免疫方面的研究,E—mail:zmhuagz@126.com。
  • 相关文献

参考文献8

二级参考文献29

  • 1张宏誉,李宏,岳凤敏,王良录,方权,王瑞琦,秦万章,李明,金岚,秦立模,吴惠俐.咪唑斯汀治疗慢性特发性荨麻疹的多中心随机平行组对照的临床试验报告[J].中华微生物学和免疫学杂志,2001,21(S2):61-64. 被引量:11
  • 2胡品津,胡伏莲.中华医学会第四次全国幽门螺杆菌学术会议纪要[J].中华消化杂志,2005,25(11):698-699. 被引量:55
  • 3蔡涛,李惠.幽门螺杆菌刺激慢性荨麻疹患者外周血单个核细胞产生白介素4和γ干扰素的意义[J].临床皮肤科杂志,2007,36(6):362-363. 被引量:17
  • 4Pichat P;Angel I;Arbilla S.Anti-inflammatory properties of mizolastine after oral administration on arachidonic acid-induced cutaneous reaction in the rat,1998(01).
  • 5Benavides J;Schoemaker H;Dana C.In vivo and in vitro interaction of the novel selective histamine H1 receptor antagonist mizolastine with H1 receptors in the rodent,1995.
  • 6Dubertr;Murrieta Aguttes M;Tonet J.Efficacy and safety of mizolastine 10 mg in a placebo-controlled comparison with loratadine in chronic idiopathic urticaria:results of the MILOR Study[J],1999.
  • 7Sabbah A;Daele J;Wade AG.Comparison of the efficacy,safety,and onset of action of mizolastine,cetirizine,and placebo in the management of seasonal allergic rhinoconjunctivitis.MIZOCET Study Group[J],1999.
  • 8Leynadier F;Duarte-Risselin C;Murrieta M.Comparative therapeutic effect and safety of mizolastine and loratadine in chronic idiopathic urticaria URTILOR study group,2000.
  • 9孙琦巍,李书云,刘学彦.慢性荨麻疹患者幽门螺杆菌检测的初步分析[J].中华皮肤科杂志,2000,33(4):275.
  • 10Marshall BJ,Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration [J]. Lancet, 1984,1 (8390) : 1311-1315.

共引文献212

同被引文献106

引证文献14

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部